
Dr. Nancy Ann Dawson M.D.
Hematologist-Oncologist | Hematology & Oncology
22 S Greene St Baltimore MD, 21201About
Dr. Nancy Dawson is a hematologist oncologist practicing in Baltimore, MD. Dr. Dawson specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Georgetown Univ Sch of Med, Washington Dc 1979
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Bisphosphonates: their evolving role in the management of prostate cancer-related bone disease.
- Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease.
- Point: It's never too soon.
- Update on hormone-refractory prostate cancer.
- A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma.
- New molecular targets in advanced prostate cancer.
- Targeted therapy in prostate cancer--are we our own worst enemy?
- Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial
- Emerging therapies in castrate-resistant prostate cancer.
- Novel treatment methods for localized prostate cancer: hypofractionated robotic radiation therapy and adjuvant chemotherapy.
- Update on castrate-resistant prostate cancer: 2010.
- A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.
- Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-b
- Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer.
- Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives.
Dr. Nancy Ann Dawson M.D.'s Practice location
Practice At 22 S Greene St
22 S Greene St -Baltimore, MD 21201Get Direction
Dr. Nancy Ann Dawson M.D.'s reviews
Write ReviewRecommended Articles
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- Black Sabbath's Tony Iommi Discusses Struggles with Lymphoma
Tony Iommi is one of the few rock and roll legends who can say that they fulfilled the industry’s cliché act of getting the band back together. In 2011, the loss of a good friend brought the Black Sabbath guitarist Iommi back into contact with the band’s original lead vocalist, Ozzy Osbourne....
- How to Deal with Lymphoma Treatment Fatigue
Treatment fatigue is a very common problem among lymphoma patients. Whether the patient is doing pharmaceutical treatments, chemotherapy, or other treatments, they will likely lead to fatigue and a feeling of being burnt out.This article will go over what treatment fatigue is, symptoms that are...
- 'Robocop' Stem Cells Developed to Fight Cancer
Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
- The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
- Genetic Advancements in Lymphoma Treatment
Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
Nearby Providers
- Dr. Yin Wu MD2401 W BELVEDERE AVE BALTIMORE MD 21215
- Ugochukwu A. Odo5406 FAIRLAWN AVE BALTIMORE MD 21215
- Dr. Jean Yared M.D.22 S Greene St Baltimore MD 21201
- Dr. Cristina I Truica M.D.2401 W Belvedere Avenue Baltimore MD 21215
- Dr. Vered Stearns M.D.1800 Orleans St Baltimore MD 21287
- Dr. Ann Butler Zimrin M.D.22 S Greene St Baltimore MD 21201
Nearest Hospitals
BON SECOURS HOSPITALl
2000 W BALTIMORE STREET BALTIMORE MD 21223